A recent study suggests that people who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise regimens.
Published data in a prominent health publication shows that while overweight people often shed a large proportion of their total mass while using the jabs, the mass is regained at an average rate of 0.8 kg per month once they quit.
"People purchasing such drugs need to be aware of the risk of rapid weight regain when the medication is stopped," stated researcher Dr. Susan Jebb.
Such speed of recovery means a return to original mass in about one and a half years.
Comparing Approaches
The analysis, which examined dozens of trials involving over 9,000 of patients, compared the outcomes of GLP-1 agonists with older methods.
Scientists point out that individuals who shed pounds through lifestyle changes alone typically have a less rapid weight regain—around 0.1 kg a month—post-intervention.
Understanding the Fast Rebound
Experts suggest the way of the injections is key to understanding the heightened rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production could lead to the system to produce less of its endogenous hormone, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this hormone supplement results in hunger is uncontrolled, making overeating a significant risk."
A Chronic Issue?
Medical guidelines advise the injections for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.
Many experts say that, given the significant potential of weight regain, the treatment might need to be long-term.
This view is reinforced by pharmaceutical companies, who state that the results "highlight the chronic character of excess weight," comparing it to managing diseases like diabetes.
Patient Accounts
Individuals who have discontinued the medication report a powerful return of cravings.
"It was like something that goes on and I was suddenly starving," recalled one woman.
This challenge is exacerbated if individuals have not adopted sustainable lifestyle or habit changes during therapy.
Widespread Interest
Survey data suggest that millions of people in the UK have used these injections in the past year, with interest being substantial.
- Adoption is greater among females compared to men.
- The 40s and 50s age group shows the greatest usage rates.
- Many access the drugs through private prescriptions rather than public health services.
Ultimately, experts emphasize that while these medications are potent agents for shedding pounds, they are not a standalone fix and long-term success relies on combined lifestyle support.
